Authors: SCHOCH C RIEDER H STOLLMANNGIBBELS B FREUND M TISCHLER HJ SILLINGENGELHARDT G FONATSCH C

Citation: C. Schoch et al., 17P ANOMALIES IN LYMPHOID MALIGNANCIES - DIAGNOSTIC AND PROGNOSTIC IMPLICATIONS, Leukemia & lymphoma, 17(3-4), 1995, pp. 271-279

Authors: FONATSCH C GUDAT H LENGFELDER E WANDT H SILLINGENGELHARDT G LUDWIG WD THIEL E FREUND M BODENSTEIN H SCHWIEDER G GRUNEISEN A AUL C SCHNITTGER S RIEDER H HAASE D HILD F

Citation: C. Fonatsch et al., CORRELATION OF CYTOGENETIC FINDINGS WITH CLINICAL-FEATURES IN 18 PATIENTS WITH INV(3)(Q21Q26) OR T(3,3)(Q21,Q26), Leukemia, 8(8), 1994, pp. 1318-1326

Authors: SILLINGENGELHARDT G FEGELER W ROOS N SCHOMAKER R ESSINK M BUCHNER T

Citation: G. Sillingengelhardt et al., EARLY EMPIRIC ANTIFUNGAL TREATMENT OF INFECTIONS IN NEUTROPENIC PATIENTS COMPARING FLUCONAZOLE (FCA) WITH AMPHOTERICIN-B 5-FLUCYTOSINE (ABF)/, Blood, 84(10), 1994, pp. 10000306-10000306

Authors: VERSTRAETE M NURMOHAMED M KIENAST J SIEBECK M SILLINGENGELHARDT G BULLER H HOET B BICHLER J CLOSE P BREDDIN JHK MARBET GA SCHRAMM W TENCATE JW BULLER HR NURMOHAMED MT ARNOUT J HOET B SPANNAGL M RING J FRITZ H VANDELOO J

Citation: M. Verstraete et al., BIOLOGIC EFFECTS OF RECOMBINANT HIRUDIN (CGP-39393) IN HUMAN VOLUNTEERS, Journal of the American College of Cardiology, 22(4), 1993, pp. 1080-1088

Authors: MARBET GA VERSTRAETE M KIENAST J GRAF P HOET B TSAKIRIS DA SILLINGENGELHARDT G CLOSE P

Citation: Ga. Marbet et al., CLINICAL-PHARMACOLOGY OF INTRAVENOUSLY ADMINISTERED RECOMBINANT DESULFATOHIRUDIN (CGP-39393) IN HEALTHY-VOLUNTEERS, Journal of cardiovascular pharmacology, 22(3), 1993, pp. 364-372